I am a recent Cornell Computer and Information Science grad working on developing software. My interests emerged with the inescapable curiosity for the intersection of technology, medicine, business, and design, and I was drawn to the gratification that comes with building things to help many people. At Cornell, I discovered various ways to impact healthcare. Merck, MITRE, and the Englander Intitute for Precision Medicine were vehicles that enabled me to explore my desire to create a lasting impact in healthcare technology.
HoloGraph is a graph visualization application in mixed reality aims to help researchers identify patterns in cancer/drug networks! HoloGraph was developed at the Englander Intitute for Precision Medicine at Weill Cornell Medicine. I had the honor to create and port features from HoloLens 1 to HoleLens 2 and Oculus 2 under Professors Alexandros Sigaras and Olivier Elemento!
Tiempo is a platform emboldening undocumented immigrants in NYC to seek last-minute, non-emergency care on their own schedule. It provides public clinics and FQHC wait times. Additionally, collaboration with clinics allows users to schedule same-day appointments.
Brain computer interface (BCI) incorporates a portable electroencephalogram (EEG) that uses an open source headset (the Ultracortex by OpenBCI) and a new software analysis tool to increase autonomy for amyotrophic lateral sclerosis (ALS) patients. The device exploits changes observed in the brainwaves of ALS patients in response to special visual stimuli and displays letters on a computer screen. The end result is a noninvasive and relatively inexpensive tool with the potential to allow ALS patients with limited mobility to control their environments as well as communicate with families and loved ones in real time.
Our project was awarded the Design Excellence Award at the 2019 Biomedical Engineering Presentation.
Passive targeting in Nanomedicine is a chapter from the book Nanoparticles for Biomedical Applications, which focuses on fundamental concepts, body interactions, and clinical potential of passive targeting in nanomedicine. I was fortunate enough to collaborate with six exceptional peers to publish this book chapter!